OnabotulinumtoxinA Bladder Injection Study

Summary

Patients with overactive bladder (OAB) will be randomly assigned (like a flip of a coin) to receive 100 units of onabotulinumtoxinA injected into the bladder at either 3 sites or 10 sites. Patient satisfaction and the effectiveness of the medication will be evaluated.

Timeline

Start

2018-08-08

Primary completion

2020-09-01

Completion

2020-09-01

Outcome

Outcome not reported

Stopped (Enrollment): “Lack of enrollment”

Drugs

Indications